Compositions and methods for aptamer screening
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
C12Q-001/6886
G01N-033/574
G01N-033/50
G01N-033/53
C12Q-001/68
C12N-015/10
출원번호
US-0652728
(2013-12-19)
등록번호
US-9939443
(2018-04-10)
국제출원번호
PCT/US2013/076611
(2013-12-19)
국제공개번호
WO2014/100434
(2014-06-26)
발명자
/ 주소
Spetzler, David
Domenyuk, Valeriy
Hornung, Tassilo
Mayer, Günter
Famulok, Michael
출원인 / 주소
Caris Life Sciences Switzerland Holdings GmbH
대리인 / 주소
Thomas, Jeffrey G.
인용정보
피인용 횟수 :
0인용 특허 :
192
초록▼
Methods are provided for selecting aptamers that are specific to a target of interest from amongst a library of potential aptamer sequences. Aptamers disclosed can be used to detect and/or characterize biological entities of interest, e.g. microvesicles and/or surface antigens. Further disclosed are
Methods are provided for selecting aptamers that are specific to a target of interest from amongst a library of potential aptamer sequences. Aptamers disclosed can be used to detect and/or characterize biological entities of interest, e.g. microvesicles and/or surface antigens. Further disclosed are biomarkers that can be used for diagnosing different disorders including different types of cancer.
대표청구항▼
1. A method of identifying at least one aptamer comprising: (a) providing a pool of candidate aptamers;(b) contacting a first at least one biological sample with the pool provided in step (a), wherein the first at least one biological sample comprises a microvesicle population;(c) identifying a firs
1. A method of identifying at least one aptamer comprising: (a) providing a pool of candidate aptamers;(b) contacting a first at least one biological sample with the pool provided in step (a), wherein the first at least one biological sample comprises a microvesicle population;(c) identifying a first subpool of candidate aptamers that bound at least one microvesicle in the first at least one biological sample in step (b);(d) contacting a second at least one biological sample with the pool provided in step (a), wherein the second at least one biological sample comprises a microvesicle population;(e) identifying a second subpool of candidate aptamers that bound at least one microvesicle in the second at least one biological sample in step (d); and(f) comparing the members of the first and second subpools of candidate aptamers to identify at least one member of a pool that is overrepresented in one of the subpools versus the other subpool, thereby identifying the at least one aptamer. 2. The method of claim 1, wherein each of the first at least one biological sample is separately contacted with aliquots of the pool in step (b). 3. The method of claim 1, wherein each of the second at least one biological sample is separately contacted with aliquots of the pool in step (d). 4. The method of claim 1, further comprising repeating steps (b)-(c) at least 1 time prior to step (f), wherein the first subpool of candidate aptamers from step (c) is used as the starting pool of candidate aptamers when repeating step (b). 5. The method of claim 1, further comprising repeating steps (d)-(e) at least 1 time prior to step (f), wherein the second subpool of candidate aptamers from step (e) is used as the starting pool of candidate aptamers when repeating step (d). 6. The method of claim 1, further comprising repeating steps (a)-(f) at least 1 time, wherein the identified one aptamer from step (f) is used as the starting pool of candidate aptamers when repeating step (a). 7. The method of claim 1, wherein the first at least one biological sample comprises a diseased sample. 8. The method of claim 7, wherein each of the first at least one biological sample comprises a sample representative of a same disease. 9. The method of claim 7, wherein the second at least one biological sample comprises a non-diseased sample. 10. The method of claim 7, wherein the first at least one biological sample comprises a same disease as the second at least one biological sample, and wherein the disease in the first and second samples differs in at least one of clinical stage, pathologic stage, aggressiveness, growth rate, receptor status, prior treatment, response to a same to treatment, and response to different treatments. 11. The method of claim 7, wherein the disease comprises a cancer. 12. The method of claim 11, wherein the cancer comprises a prostate cancer, a lung cancer, a breast cancer, a brain cancer, an ovarian cancer, a colorectal cancer, or a melanoma. 13. The method of claim 1, wherein the first at least one biological sample and the second at least one biological sample comprise bodily fluids. 14. The method of claim 13, wherein the bodily fluid comprises peripheral blood, sera, plasma, ascites, urine, cerebrospinal fluid (CSF), sputum, saliva, bone marrow, synovial fluid, aqueous humor, amniotic fluid, cerumen, breast milk, broncheoalveolar lavage fluid, semen, prostatic fluid, cowper's fluid or pre-ejaculatory fluid, female ejaculate, sweat, fecal matter, tears, cyst fluid, pleural and peritoneal fluid, pericardial fluid, lymph, chyme, chyle, bile, interstitial fluid, menses, pus, sebum, vomit, vaginal secretions, mucosal secretion, stool water, pancreatic juice, lavage fluids from sinus cavities, bronchopulmonary aspirates, blastocyl cavity fluid, umbilical cord blood, or a derivative of any thereof. 15. The method of claim 13, wherein the bodily fluid comprises peripheral blood, plasma, serum or a derivative of any thereof. 16. The method of claim 1, wherein the biological sample comprises a tissue sample or cell culture sample. 17. The method of claim 1, wherein the identifying in step (c) and/or step (e) comprises sequencing the candidate aptamers that bound the at least one microvesicle. 18. The method of claim 17, wherein comparing the members of the first and second subpools in step (f) comprises comparing the sequences of the aptamers identified in step (c) and/or step (e). 19. The method of claim 1, further comprising filtering the identified at least one aptamer. 20. The method of claim 19, wherein filtering the identified at least one aptamer comprises calculating a stability of the at least one aptamer, identifying a secondary structure of the at least one aptamer, and/or separately contacting each of the at least one aptamer with a biological sample.
Liberti Paul A. (Churchville PA) Feeley Brian P. (Easton PA) Gohel Dhanesh I. (Philadelphia PA), Apparatus for magnetic separation featuring external magnetic means.
Manoharan, Muthiah; Maier, Martin; Jayaraman, Muthusamy; Matsuda, Shigeo; Jayaprakash, Narayanannair K.; Rajeev, Kallanthottathil G.; Akinc, Akin; Baillie, Thomas A., Biodegradable lipids for the delivery of active agents.
Schlessinger Joseph (New York NY) Skolnik Edward Y. (New York NY) Margolis Benjamin L. (New York NY), Expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target proteins.
Sullenger, Bruce A.; Layzer, Juliana M.; Rusconi, Christopher P.; Oney, Sabah; Que-Gewirth, Nanette L. S., Focused libraries, functional profiling, laser SELEX, and DESELEX.
Polisky Barry (Boulder CO) Jenison Robert D. (Boulder CO) Gold Larry (Boulder CO), High-affinity nucleic acid ligands that discriminate between theophylline and caffeine.
Nieuwlandt Dan T. (Boulder CO) Gold Larry (Boulder CO) Wecker Matthew (Boulder CO), High-affinity oligonucleotide ligands to the tachykinin substance P.
Liberti Paul A. (Churchville PA), Immunoassay system and procedure based on precipitin-like interaction between immune complex and Clq or other non-immuno.
Owen Charles S. (Swarthmore PA) Silvia John C. (Warminster PA) D\Angelo Louis (Berlin NJ) Liberti Paul A. (Churchville PA), Magnetic-polymer particles.
Pugia,Michael J.; Profitt,James A.; Blankenstein,Gert; Peters,Ralf Peter, Method and apparatus for splitting of specimens into multiple channels of a microfluidic device.
Smulson Mark E. (Washington DC) Bhatia Kishor (Arbutus MD) Huppi Konrad (Reston VA), Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for hu.
Unger,Marc A.; Chou,Hou Pu; Thorsen,Todd A.; Scherer,Axel; Quake,Stephen R.; Liu,Jian; Adams,Mark L.; Hansen,Carl L., Method of forming a via in a microfabricated elastomer structure.
Rossomando Edward F. (West Hartford CT) Hadjimichael Jane (Simsbury CT), Method of using magnetic particles for isolating, collecting and assaying diagnostic ligates.
Schueller, Olivier J. A.; Duffy, David C.; Rogers, John A.; Brittain, Scott T.; Whitesides, George M., Methods for fabricating microfluidic structures.
Unger, Marc A.; Chou, Hou-Pu; Thorsen, Todd A.; Scherer, Axel; Quake, Stephen R.; Enzelberger, Markus M.; Adams, Mark L.; Hansen, Carl L., Microfabricated elastomeric valve and pump systems.
Unger, Marc A.; Chou, Hou-Pu; Thorsen, Todd A.; Scherer, Axel; Quake, Stephen R.; Enzelberger, Markus M.; Adams, Mark L.; Hansen, Carl L., Microfabricated elastomeric valve and pump systems.
Storek,David; Schneeberger,Niklaus; Otillar, Jr.,Robert P.; Krozer,Anatol, Microfluidic device and method with trapping of sample in cavities having lids that can be opened or closed.
Storek,David; Schneeberger,Niklaus; Ottosson,Britta; Krozer,Anafol; Otillar, Jr.,Robert P, Microfluidic device and method with trapping of sample in cavities having lids that can be opened or closed.
Jeon,Noo Li; Cotman,Carl; Taylor,Anne M., Microfluidic device for enabling fluidic isolation among interconnected compartments within the apparatus and methods relating to same.
Ekstrm Bjrn (Upsala SEX) Jacobson Gunilla (Upsala SEX) Ohman Ove (Upsala SEX) Sjdin Hakan (Upsala SEX), Microfluidic structure and process for its manufacture.
Simmons,Blake; Domeier,Linda; Woo,Noble; Shepodd,Timothy; Renzi,Ronald F., Microfluidic structures and methods for integrating a functional component into a microfluidic device.
Anderson, Janelle R.; Cherniavskaya, Oksana; Chiu, Daniel T.; Jackman, Rebecca J.; McDonald, Cooper; Whitesides, George M., Microfluidic systems including three-dimensionally arrayed channel networks.
Eckstein Fritz (Gottingen DEX) Pieken Wolfgang (Boulder CO) Benseler Fritz (Gleichen/Etzborn DEX) Olsen David B. (West Point PA) Williams David M. (Cambridge GB2) Heidenreich Olaf (Gottingen DEX), Modified ribozymes.
Eckstein Fritz (Gottingen DEX) Pieken Wolfgang (Boulder CO) Benseler Fritz (Gleichen/Etzborn DEX) Olsen David B. (West Point PA) Williams David M. (Cherry Hinton GB2) Heindenreich Olaf (Gottingen DEX, Modified ribozymls.
Von Hoff, Daniel D.; Wright, Alan; McGinniss, Matthew J.; Bender, Ryan P.; Loesch, David M.; Alarcon, Arlet; Penny, Robert J.; Pawlowski, Traci, Molecular profiling of tumors.
Heil, James R.; Schneider, Daniel J.; Nieuwlandt, Daniel T.; Wilcox, Sheri K.; Zichi, Dominic; Gander, Todd; Eaton, Bruce; Gold, Larry, Multiplexed analyses of test samples.
Chandler,Don J.; Chandler,Van S.; Lambert,Beth A.; Reber,Janet J.; Phipps,Stacie L., Precision fluorescently dyed polymeric microparticles and methods of making and using same.
Blake, Deborah Adella; Gilliver, Lissa Gwyneth; Henry, Stephen Michael; Chen, Ji, Sensitivity controls for blood serology prepared from modified cells.
Breidford, Wayne; Lancaster, Christy A; Hayenga, Jon Wallace; Bardell, Ronald L; Tonn, Jeffrey F; Weigl, Bernhard H, System and method for heating, cooling and heat cycling on microfluidic device.
Biesecker Greg (Boulder CO) Jayasena Sumedha D. (Boulder CO) Gold Larry (Boulder CO) Smith Drew (Boulder CO) Kirschenheuter Gary P. (Arvada CO), Systematic evolution of ligands by exponential enrichment: blended SELEX.
Burke Donald (Boulder CO) Tarasow Ted (Boulder CO) Eaton Bruce E. (Boulder CO) Gold Larry (Boulder CO), Systematic evolution of ligands by exponential enrichment: chimeric selex.
Gold Larry ; Willis Michael ; Koch Tad ; Ringquist Steven ; Jensen Kirk ; Atkinson Brent, Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex.
Jensen Kirk B. ; Chen Hang ; Morris Kevin N.,ATX ; Stephens Andrew ; Gold Larry, Systematic evolution of ligands by exponential enrichment: tissue SELEX.
Jensen Kirk B ; Chen Hang ; Morris Kevin N.,ATX ; Stephens Andrew ; Gold Larry, Systematic evolution of ligands by exponential enrichment: tissue selex.
Jensen Kirk B. ; Chen Hang ; Morris Kevin N.,ATX ; Stephens Andrew ; Gold Larry, Systematic evolution of ligands by exponential enrichment: tissue selex.
Jensen Kirk B. ; Chen Hang ; Morris Kevin N.,ATX ; Stephens Andrew ; Gold Larry, Systematic evolution of ligands by exponential enrichment: tissue selex.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.